A further prospective, multicentric, larger study comparing thalassemia-associated cardiometabolic abnormalities with the gold standard of iron overload assessment (T2*MRI) is recommended to confirm our findings and validate the diagnostic and prognostic performance of FABP4. This evidence concerns the gene FABP4 and thalassemia.